SpO2 Infant and Pediatric Study

← catalyst calendar

NCT07615738 · readout in 285 d

Sponsored by GE Healthcare (industry) · GEHC — their whole pipeline →.

Phase

Not applicable

Status

Not yet recruiting

Study type

Interventional

Design

Na · None · Device feasibility

Enrollment

180estimated

Sites

Country

United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2026-06-15

estimated

When the study began enrolling

Primary completion

2027-05-31

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2027-12-31

estimated

The whole study's end, after follow-up

First posted

2026-05-29

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-07-01

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

SpO2 (Peripheral Oxygen Saturation) Measurement Validation
SpO2

Intervention

Device: SpO2 Sensor

Primary outcome

what the primary-completion date above is the date OF

Collection of SpO2 Percentage Sensor Data with simultaneous SaO2 values

measured From enrollment to the end of standard of care arterial cannulation, approximately 1 week.

Publications

PMID 17613642 — cited as background
PMID 36939727 — cited as background
PMID 34772785 — cited as background
PMID 15791098 — cited as background

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · GEHC's whole pipeline · Catalyst calendar · Every registered study · What changed